Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Immuron Limited
< Previous
1
2
Next >
Immuron Letter to Shareholders: Projects Update
May 30, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® highest sales in history
April 10, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
March 05, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® continued strong sales growth
January 17, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
January 15, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Travelan® Clinical Trial Update
January 14, 2025
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th
December 02, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event
November 21, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
October 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® continued strong sales growth
October 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
October 04, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Plans Phase 2 Trial for IMM-529 following FDA review
September 05, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
August 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
August 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
August 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron announces record Travelan® sales globally, Australia and USA
July 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron requests pre-IND meeting for IMM-529 with FDA filing
July 02, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
June 05, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO Steven Lydeamore to present at Peak Sky High
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Board Changes
May 31, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Limited to Present at the Emerging Growth Conference
May 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Director Resignation
May 03, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron to host Live Virtual Event
April 15, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Travelan® sales continued strong growth
April 10, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
March 07, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Presentation Australian Biologics Festival 2024
February 21, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record Travelan® sales
February 13, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
February 08, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron achieves record half yearly Travelan® sales
January 16, 2024
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
Immuron Clinical Trials Update
December 22, 2023
From
Immuron Limited
Via
GlobeNewswire
Tickers
ASX:IMC
IMRN
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.